|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yanamoto S, Yamada S, Takahashi H,
Yoshitomi I, Kawasaki G, Ikeda H, Minamizato T, Shiraishi T, Fujita
S, Ikeda T, et al: Clinicopathological risk factors for local
recurrence in oral squamous cell carcinoma. Int J Oral Maxillofac
Surg. 41:1195–1200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang B, Zhang S, Yue K and Wang XD: The
recurrence and survival of oral squamous cell carcinoma: A report
of 275 cases. Chin J Cancer. 32:614–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Agra IM, Carvalho AL, Pinto CA, Martins
EP, Filho JG, Soares FA and Kowalski LP: Biological markers and
prognosis in recurrent oral cancer after salvage surgery. Arch
Otolaryngol Head Neck Surg. 134:743–749. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalavrezos N and Bhandari R: Current
trends and future perspectives in the surgical management of oral
cancer. Oral Oncol. 46:429–432. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ord RA, Kolokythas A and Reynolds MA:
Surgical salvage for local and regional recurrence in oral cancer.
J Oral Maxillofac Surg. 64:1409–1414. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schwartz GJ, Mehta RH, Wenig BL, Shaligram
C and Portugal LG: Salvage treatment for recurrent squamous cell
carcinoma of the oral cavity. Head Neck. 22:34–41. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Søland TM and Brusevold IJ: Prognostic
molecular markers in cancer - quo vadis? Histopathology.
63:297–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Huang TY, Hsu LP, Wen YH, Huang TT, Chou
YF, Lee CF, Yang MC, Chang YK and Chen PR: Predictors of
locoregional recurrence in early stage oral cavity cancer with free
surgical margins. Oral Oncol. 46:49–55. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chauhan SS, Kaur J, Kumar M, Matta A,
Srivastava G, Alyass A, Assi J, Leong I, MacMillan C, Witterick I,
et al: Prediction of recurrence-free survival using a protein
expression-based risk classifier for head and neck cancer.
Oncogenesis. 4:e1472015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Komatsu S, Ichikawa D, Hirajima S,
Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Arita T, Konishi H,
Shiozaki A, et al: Plasma microRNA profiles: Identification of
miR-25 as a novel diagnostic and monitoring biomarker in
oesophageal squamous cell carcinoma. Br J Cancer. 111:1614–1624.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cortez MA and Calin GA: MicroRNA
identification in plasma and serum: A new tool to diagnose and
monitor diseases. Expert Opin Biol Ther. 9:703–711. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Momen-Heravi F, Trachtenberg AJ, Kuo WP
and Cheng YS: Genomewide study of salivary microRNAs for detection
of oral cancer. J Dent Res. 93 Suppl 7:86S–93S. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA. 105:pp.
10513–10518. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Witwer KW: Circulating microRNA biomarker
studies: Pitfalls and potential solutions. Clin Chem. 61:56–63.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cappelletti V, Appierto V, Tiberio P, Fina
E, Callari M and Daidone MG: Circulating biomarkers for prediction
of treatment response. J Natl Cancer Inst Monogr. 2015:60–63. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tiberio P, Callari M, Angeloni V, Daidone
MG and Appierto V: Challenges in using circulating miRNAs as cancer
biomarkers. BioMed Res Int. 2015:7314792015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Allegra A, Alonci A, Campo S, Penna G,
Petrungaro A, Gerace D and Musolino C: Circulating microRNAs: New
biomarkers in diagnosis, prognosis and treatment of cancer
(Review). Int J Oncol. 41:1897–1912. 2012.PubMed/NCBI
|
|
23
|
Schwarzenbach H, Nishida N, Calin GA and
Pantel K: Clinical relevance of circulating cell-free microRNAs in
cancer. Nat Rev Clin Oncol. 11:145–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Iorio MV and Croce CM: MicroRNA
dysregulation in cancer: Diagnostics, monitoring and therapeutics.
A comprehensive review. EMBO Mol Med. 4:143–159. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gomes CC, de Sousa SF and Gomez RS:
MicroRNAs: Small molecules with a potentially role in oral squamous
cell carcinoma. Curr Pharm Des. 19:1285–1291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu BH, Xiong XP, Jia J and Zhang WF:
MicroRNAs: New actors in the oral cancer scene. Oral Oncol.
47:314–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soga D, Yoshiba S, Shiogama S, Miyazaki H,
Kondo S and Shintani S: microRNA expression profiles in oral
squamous cell carcinoma. Oncol Rep. 30:579–583. 2013.PubMed/NCBI
|
|
28
|
Zahran F, Ghalwash D, Shaker O, Al-Johani
K and Scully C: Salivary microRNAs in oral cancer. Oral Dis.
21:739–747. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hanash SM, Baik CS and Kallioniemi O:
Emerging molecular biomarkers - blood-based strategies to detect
and monitor cancer. Nat Rev Clin Oncol. 8:142–150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu JY, Yi C, Chung HR, Wang DJ, Chang WC,
Lee SY, Lin CT, Yang YC and Yang WC: Potential biomarkers in saliva
for oral squamous cell carcinoma. Oral Oncol. 46:226–231. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ries J, Vairaktaris E, Agaimy A, Kintopp
R, Baran C, Neukam FW and Nkenke E: miR-186, miR-3651 and miR-494:
Potential biomarkers for oral squamous cell carcinoma extracted
from whole blood. Oncol Rep. 31:1429–1436. 2014.PubMed/NCBI
|
|
32
|
Ries J, Vairaktaris E, Kintopp R, Baran C,
Neukam FW and Nkenke E: Alterations in miRNA expression patterns in
whole blood of OSCC patients. In Vivo. 28:851–861. 2014.PubMed/NCBI
|
|
33
|
Masood Y, Kqueen CY and Rajadurai P: Role
of miRNA in head and neck squamous cell carcinoma. Expert Rev
Anticancer Ther. 15:183–197. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ganci F, Sacconi A, Manciocco V, Sperduti
I, Battaglia P, Covello R, Muti P, Strano S, Spriano G, Fontemaggi
G, et al: MicroRNA expression as predictor of local recurrence risk
in oral squamous cell carcinoma. Head Neck. 38 Suppl 1:E189–E197.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xiao W, Bao ZX, Zhang CY, Zhang XY, Shi
LJ, Zhou ZT and Jiang WW: Upregulation of miR-31* is negatively
associated with recurrent/newly formed oral leukoplakia. PLoS One.
7:e386482012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gorenchtein M, Poh CF, Saini R and Garnis
C: MicroRNAs in an oral cancer context - from basic biology to
clinical utility. J Dent Res. 91:440–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kowalski LP and Sanabria A: Elective neck
dissection in oral carcinoma: A critical review of the evidence.
Acta Otorhinolaryngol Ital. 27:113–117. 2007.PubMed/NCBI
|
|
39
|
Grimm M, Kraut W, Hoefert S, Krimmel M,
Biegner T, Teriete P, Cetindis M, Polligkeit J, Kluba S, Munz A, et
al: Evaluation of a biomarker based blood test for monitoring
surgical resection of oral squamous cell carcinomas. Clin Oral
Investig. 20:329–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gomes CC and Gomez RS: MicroRNA and oral
cancer: Future perspectives. Oral Oncol. 44:910–914. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yoshizawa JM and Wong DT: Salivary
microRNAs and oral cancer detection. Methods Mol Biol. 936:313–324.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zen K and Zhang CY: Circulating microRNAs:
A novel class of biomarkers to diagnose and monitor human cancers.
Med Res Rev. 32:326–348. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Summerer I, Niyazi M, Unger K, Pitea A,
Zangen V, Hess J, Atkinson MJ, Belka C, Moertl S and Zitzelsberger
H: Changes in circulating microRNAs after radiochemotherapy in head
and neck cancer patients. Radiat Oncol. 8:2962013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gombos K, Horváth R, Szele E, Juhász K,
Gocze K, Somlai K, Pajkos G, Ember I and Olasz L: miRNA expression
profiles of oral squamous cell carcinomas. Anticancer Res.
33:1511–1517. 2013.PubMed/NCBI
|
|
45
|
Komatsu S, Ichikawa D, Takeshita H,
Tsujiura M, Morimura R, Nagata H, Kosuga T, Iitaka D, Konishi H,
Shiozaki A, et al: Circulating microRNAs in plasma of patients with
oesophageal squamous cell carcinoma. Br J Cancer. 105:104–111.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW
and Lin SC: Increase of microRNA miR-31 level in plasma could be a
potential marker of oral cancer. Oral Dis. 16:360–364. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lin SC, Liu CJ, Lin JA, Chiang WF, Hung PS
and Chang KW: miR-24 up-regulation in oral carcinoma: Positive
association from clinical and in vitro analysis. Oral Oncol.
46:204–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Liu CJ, Lin SC, Yang CC, Cheng HW and
Chang KW: Exploiting salivary miR-31 as a clinical biomarker of
oral squamous cell carcinoma. Head Neck. 34:219–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Grimm M, Schmitt S, Teriete P, Biegner T,
Stenzl A, Hennenlotter J, Muhs HJ, Munz A, Nadtotschi T, König K,
et al: A biomarker based detection and characterization of
carcinomas exploiting two fundamental biophysical mechanisms in
mammalian cells. BMC Cancer. 13:5692013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Friedman EB, Shang S, de Miera EV, Fog JU,
Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, et
al: Serum microRNAs as biomarkers for recurrence in melanoma. J
Transl Med. 10:1552012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Maclellan SA, Lawson J, Baik J, Guillaud
M, Poh CF and Garnis C: Differential expression of miRNAs in the
serum of patients with high-risk oral lesions. Cancer Med.
1:268–274. 2012. View Article : Google Scholar : PubMed/NCBI
|
